Follow the people · Insider

JL

Jennifer Kayden Lee

Insider · EVP, Head of North America · RYTM

Jennifer Kayden Lee files insider transactions with the SEC as an evp, head of north america of Rhythm Pharmaceuticals (RYTM). We hold 1 disclosed purchase or sale filed since 4 February 2020, 1 of them in the last 90 days.

  • Files forRYTM
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure14 August 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 9 November 202013 August 2026EVP, Head of North America · Rhythm Pharmaceuticals (RYTM)111 Form 4 lines · source: SEC Form 4
  • Filed 31 January 202031 January 2020Chief Commercial Officer · Krystal Biotech (KRYS)1 Form 4 line · source: SEC Form 4

Everything they disclosed

112 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.